Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

The randomized, controlled PALISADE trial demonstrated the benefit of daily oral immunotherapy with Peanut (Arachis Hypogaea) allergen powder-dnfp (PTAH, formerly AR101) in peanut-allergic children and adolescents.ARC004, the open-label follow-on study to PALISADE, used 5 dosing cohorts to explore P...

全面介紹

Saved in:
書目詳細資料
Main Authors: Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernández‐Rivas, Katharina Blümchen, Jonathan O’B Hourihane, Kirsten Beyer, Aikaterini Anagnostou, Amal Assa’ad, Moshe Ben‐Shoshan, J. Andrew Bird, Tara F. Carr, Warner Carr, Thomas B. Casale, Hey Chong, Christina E. Ciaccio, Morna J. Dorsey, Stanley M. Fìneman, Stephen B. Fritz, Alexander N. Greiner, Leon S. Greos, Frank C. Hampel, María Ibáñez-Vea, David Jeong, Douglas Johnston, Rita Kachru, Edwin Kim, Bruce J. Lanser, Stephanie A. Leonard, Mary C. Maier, Lyndon E. Mansfield, Antonella Muraro, Jason Ohayon, J. N. G. Oude Elberink, Daniel Petroni, Jacqueline A. Pongracic, Jay M. Portnoy, Rima Rachid, Ned T. Rupp, Georgiana Sanders, Hemant Sharma, Vibha Sharma, Ellen Sher, Lawrence Sher, Sayantani Sindher, Dareen Siri, Jonathan M. Spergel, A. B. Sprikkelman, Gordon L. Sussman, Marina Tsoumani, Pooja Varshney, Girish Vitalpur, Julie Wang, William H. Yang, José Manuel Zubeldia, Alex Smith, Robert Ryan, Daniel C. Adelman
格式: Artigo
語言:英语
出版: 2020
在線閱讀:https://doi.org/10.1016/j.jaip.2020.12.029
http://www.jaci-inpractice.org/article/S2213219820313611/pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!